回复: [关于Lecanemab的营销后安全问题:使用FDA不良事件报告系统进行不成比例分析]
Xiaoxuan Xing1,2, Ke Wang1,2, Xianzhe Dong3,4
1Department of Pharmacy, Xuanwu Hospital of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, P R China.
本研究针对使用FAERS数据库对lecanemab安全信号的评论. 我们澄清了胰腺癌和脱复制方法报告结果不成比例的信号.
科学领域:
- 药物监督和药物安全研究.
- 对营销后监测数据的分析.
背景情况:
- 发表的一篇文章讨论了lecanemab的营销后安全问题.
- 根据食品和药物管理局的不良事件报告系统 (FAERS) 数据库提出了担忧.
研究的目的:
- 为了回应作者对先前发表的文章的评论.
- 提供关于胰腺癌不成比例报告信号 (SDR) 结果的解释.
- 为了澄清分析中使用的脱复制方法.
主要方法:
- 使用不成比例性分析进行药监测研究.
- 案例/非案例设计方法.
- 对FAERS数据库的分析.
主要成果:
- 承认作者对术语"不成比例报告信号 (SDR) "的看法.
- 提供了关于胰腺癌的SDR结果的解释.
- 详细介绍了对数据应用的脱复制方法.
结论:
- 该研究澄清了lecanemab安全信号检测的具体方面.
- 强调在药监测研究中方法细节的重要性.
- 为正在进行的关于现实世界药物安全数据解释的讨论做出贡献.
更多相关视频
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
